NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Santhera Pharmaceuticals Holding AG (SW: SANN)

 
SANN Technical Analysis
5
As on 4th Jul 2025 SANN STOCK Price closed @ 12.04 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 9.25 & Strong Buy for SHORT-TERM with Stoploss of 9.91 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

SANNSTOCK Price

Open 12.00 Change Price %
High 12.18 1 Day -0.08 -0.66
Low 11.90 1 Week 0.08 0.67
Close 12.04 1 Month -0.60 -4.75
Volume 9869 1 Year 1.86 18.27
52 Week High 17.18 | 52 Week Low 7.84
 
SW Switzerland Most Active Stocks
CSGN 0.82 0.00%
CSGN 0.82 0.00%
UBSG 27.37 -1.40%
UBSG 27.37 -1.40%
NOVN 98.12 1.36%
NOVN 98.12 1.36%
NESN 79.27 -0.40%
NESN 79.27 -0.40%
PRFN 0.03 50.00%
SWON 7.85 5.94%
 
SW Switzerland Top Gainers Stocks
CIE 0.46 53.33%
CIE 0.46 53.33%
CIE 0.46 53.33%
CIE 0.46 53.33%
CADN 0.03 50.00%
PRFN 0.03 50.00%
PRFN 0.03 50.00%
BLS 0.13 18.18%
BLS 0.13 18.18%
BLS 0.13 18.18%
 
SW Switzerland Top Losers Stocks
MBTN 0.75 -42.31%
AIRE 0.06 -14.29%
AIRE 0.06 -14.29%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
 
 
SANN
Daily Charts
SANN
Intraday Charts
Whats New @
Bazaartrend
SANN
Free Analysis
 
SANN Important Levels Intraday
RESISTANCE12.58
RESISTANCE12.41
RESISTANCE12.30
RESISTANCE12.19
SUPPORT11.89
SUPPORT11.78
SUPPORT11.67
SUPPORT11.50
 
SANN Forecast July 2025
4th UP Forecast16.53
3rd UP Forecast15.09
2nd UP Forecast14.2
1st UP Forecast13.31
1st DOWN Forecast10.77
2nd DOWN Forecast9.88
3rd DOWN Forecast8.99
4th DOWN Forecast7.55
 
SANN Weekly Forecast
4th UP Forecast13.68
3rd UP Forecast13.15
2nd UP Forecast12.83
1st UP Forecast12.50
1st DOWN Forecast11.58
2nd DOWN Forecast11.25
3rd DOWN Forecast10.93
4th DOWN Forecast10.40
 
SANN Forecast2025
4th UP Forecast32.37
3rd UP Forecast25.85
2nd UP Forecast21.82
1st UP Forecast17.79
1st DOWN Forecast6.29
2nd DOWN Forecast2.26
3rd DOWN Forecast-1.77
4th DOWN Forecast-8.29
 
 
SANN Other Details
Segment EQ
Market Capital 23832912.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
SANN Address
SANN
 
SANN Latest News
 
Your Comments and Response on Santhera Pharmaceuticals Holding AG
 
SANN Business Profile
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. It is developing Duchenne muscular dystrophy (DMD) product portfolio to treat patients irrespective of causative mutations, disease stage, or age. The company's late stage drug candidate include vamorolone, which is being developed as treatments for DMD. Its clinical stage pipeline also comprises lonodelestat (POL6014) to treat cystic fibrosis and other neutrophilic pulmonary diseases, as well as omigapil and an exploratory gene therapy approach targeting congenital muscular dystrophies. The company also out-licenses ex-North American rights to its approved product, Raxone (idebenone), for the treatment of Leber's hereditary optic neuropathy. It has collaboration agreement with Cold Spring Harbor Laboratory to investigate the potential of lonodelestat (POL6014), a potent inhibitor of human neutrophil elastase, as a therapeutic intervention for COVID-19-related acute respiratory distress syndrome. Santhera Pharmaceuticals Holding AG is headquartered in Pratteln, Switzerland. Address: Hohenrainstrasse 24, Pratteln, Switzerland, 4133
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service